期刊文献+

TLRs表达和HPV16感染与宫颈鳞癌的相关性研究 被引量:1

Relationship of Toll Like Receptors Expression and HPV16 Infection in Cervical Squamous Cell Cancer
原文传递
导出
摘要 目的分析Toll样受体(TLRs)mRNA在宫颈鳞癌和宫颈炎组织中的表达差异及与HPV16感染之间的关系,为研究TLRs在宫颈鳞癌发生发展中的作用提供依据。方法以RT-PCR方法检测80例临床组织样本中HPV16 E6和E7的表达及TLRs mRNA的表达,分析各组表达率的差异。结果未发现鳞癌组和宫颈炎组HPV16感染与TLRs mRNA表达具有相关性;鳞癌中TLR3 mRNA表达率低于宫颈炎组(P<0.05);TLRs mRNA在中分化与低分化鳞癌中的表达差异有统计学意义(P<0.05)。结论 TLR3mRNA可能与宫颈鳞癌的发病机制有关,TLRs mRNA和HPV16在宫颈鳞癌中的表达未见相关性。 Objective To analyze the relationship between Toll like receptors(TLRs)mRNA expression levels and HPV16 infection in cervical squamous cell cancer(SCC).Methods Expression levels of TLRs mRNA and HPV16 in tissue samples collected from cervical squamous carcinoma and cervicitis were detected,and the relationship of TLRs mRNA expression and HPV infection was analyzed in two different disease groups.ResultsExpressions of TLRs mRNA were not related to HPV16 infection in cervical squamous cell cancer.Expression of TLR3 mRNA in cervical SCC was significantly lower than those of cervicitis.Expression of TLR5 mRNA was shown significant difference between moderately differentiated and poorly differentiated cervical SCC(P〈0.05).Conclusion Expressions of TLRs mRNA were not related to HPV16 infection in cervical SCC.TLR3 may play a role in the pathogenesis in cervical SCC.
作者 王涛 郄明蓉 WANG Tao;QIE Ming-rong(Laboratory of Molecular Translational Medicine,Key Laboratory of Birth Defects and Related Diseases of Women and Children,Ministry of Education,West China Second University Hospital,Sichuan University,Chengdu 610041,China;Department of Obstetrics and Gynecology,West China Second University Hospital,Sichuan University,Chengdu 610041,China)
出处 《四川大学学报(医学版)》 CAS CSCD 北大核心 2018年第4期649-651,672,共4页 Journal of Sichuan University(Medical Sciences)
关键词 TLRS HPV16 宫颈鳞癌 RT-PCR TLRs HPV16 Cervical squamous cell cancer RT-PCR
  • 相关文献

参考文献2

二级参考文献29

  • 1朱静鸿,孙丽琪,刘晓杰.长春市1987~2004年宫颈癌患者死亡分析[J].中国妇幼保健,2006,21(24):3387-3388. 被引量:3
  • 2Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66. 被引量:1
  • 3Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL. A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 2000; 95:17-31. 被引量:1
  • 4Real FX, Cibrian-Uhalte E, Martinelli P. Pancreatic cancer development and progression: remodeling the model. Gastroenterology 2008; 135:724-728. 被引量:1
  • 5Tanase CP, Dima S, Mihai M, Raducan E, Nicolescu MI, Albulescu L, Voiculescu B, Dumitrascu T, Cruceru LM, Leabu M, Popescu I, Hinescu ME. Caveolin-1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma. J Mol Histo12009; 40:23-29. 被引量:1
  • 6Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, Bassi C, Falconi M, Pederzoli P, Dervenis C, Fernandez-Cruz L, Lacaine F, Pap A, Spooner D, Kerr DJ, Friess H, Bflchler MW, Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 2001; 358:1576-1585. 被引量:1
  • 7Jungert K, Buck A, von Wichert G, Adler G, Konig A, Buchholz M, Gress TM, Ellenrieder V. Spl is required for transforming growth factor-beta-induced mesenchymal transition and migration in pancreatic cancer cells. Cancer Res 2007; 67:1563-1570. 被引量:1
  • 8Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124:783-801. 被引量:1
  • 9O'Neill LA. How Toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol2006; 18:3-9. 被引量:1
  • 10Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004; 5: 975-979. 被引量:1

共引文献84

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部